FDA approves another generic abortion pill, prompting outrage from conservatives : NPR

WASHINGTON. Federal officials approved another common version of the mifeperon of abortion tablets governing formalities, which quickly caused a rollback from groups against abortion, and politicians agreed with the Trump administration.

On his website, he announced on his website that the management of products and medicines signed its inexpensive form of the tablet, which is approved for the termination of pregnancy for 10 weeks.

Students for the whole life who are opposed to abortion, in the statement on Thursday, called the approval “a spot on Trump's presidency and another sign that a deep state should go to FDA.”

Senator -Republican Josh Hawley from Missouri also criticized this step in the post on X, saying: “I lost confidence in the leadership in FDA.”

The representative of the agency stated that the FDA “has a very limited discretion when making a decision on whether the universal drug should be approved,” and added that FDA officials do not “support any product”.

Criticism arises as the main health officials of the Republican Donald Trump, including the Minister of Health Robert F. Kennedy, Jr., are faced with growing pressure from opponents of abortion to reassess mythipristone, which was approved 25 years ago and was repeatedly considered safe and effective scientists FDA.

In a letter to the Prosecutors of the Republicans last month, Kennedy and Commissioner FDA, Dr. Marty Makari, promised to conduct a complete overview of the safety of the drug.

Under Makari and Kennedy FDA, they repeatedly postponed decisions on vaccines, ultimately narrowing the approval conditions for the Covid-19 shots this year. This type of political intervention was previously very unusual in FDA, where career scientists usually make such decisions.

FDA approved the original version of Mifepristone in 2000 and gradually weakened access over time. This included the approval of the first common tablet from the manufacturer of Genbiopro medicines, in 2019.

In 2021, the FDA, under the leadership of the President of the Democratic Party, Joe Biden allowed online subsidence and delivery of the drug by mail, which significantly expands access. Since then, opponents of abortion have fought with changes.

The approval of general drugs, as a rule, is the process of a company in FDA, and numerous versions of the imitation are usually approved after the patent expiration for the original medicine. In most cases, drug manufacturers should only show that their drug corresponds to the ingredients and the formula used in the original medicine.

“This is how our system should work, and it worked in this way for decades,” said Mini -Dimmaraj about reproductive freedom for everyone. “The career of scientists and civil servants in the FDA did their job.”

FDA usually approves such applications for 10 months. But the submission of documents placed on the web file FDA shows that Evita Solutions has applied to the Mifepristone market four years ago.

On her website, Evita claims that she “believes that all people should have access to safe, affordable, high-quality, effective and compassion for abortion.”

The company said in an email that the drug will have to be launched in January next year.

The approval of the second tribalman is unlikely to affect access to a tablet, which is usually accepted with the help of another drug, a mizstol. The combination is approximately two -thirds of all US abortions. Mifepristone expands the cervix and blocks the hormone progesterone, while the Misoprostol makes the uterus of cramps and contract.

Access to the mifeperiston is limited in large areas of the country from the state of state laws that prohibit abortion, including abortion of drugs, or impose separate restrictions on the use of the drug. These laws are subject to a number of constant trials that make their way through the legal system.

Restrictions on tablets are not supported by most large medical societies, including the American Medical Association.